Cannabis in Europe: Moving with the zeitgeist

Описание: The European Cannabis Report: 7th Edition Webinar: we discuss the trends driving the European cannabis industry forward, business opportunities, legislative momentum, forging a mainstream industry - and more.

Moderator: Barbara Pastori, Director of Strategy and Data at Prohibition Partners

Speakers:
Conor O'Brien: The European Cannabis Report Analyst
Timo Bongartz: General Manager, Fluence EMEA
Dr Florian Holzapfel: Co-Founder, Cantourage
Roland Schneller: COO, Cansativa Germany

2021 was another huge year for the liberalisation and mainstreaming of cannabis in Europe. Legislation, regulations and market developments continued to evolve for the better.
Many countries continued to improve their medical cannabis access schemes, and Prohibition Partners estimates that 89,626 patients were able to access medical cannabis products in Europe for the first time, bringing the total to 284,486.

CBD products are continuing their path towards recognition as fully-legal consumer packaged goods (CPGs). During 2021, CBD was registered for the first time on the EU Cosmetic Ingredients database.

But, the story which is drawing most international attention is the upcoming liberalisation of adult-use cannabis in Europe, with the ruling coalition of Germany promising full legalisation and commercialisation of adult-use cannabis - which could be realised by the end of 2022.